TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10600077

Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) using hand instruments
Number of subjects: 359

Group type: COMPARATOR
Intervention: Conventional restorations using rotary instruments and amalgam
Number of subjects: 359

Group type: COMPARATOR
Intervention: Conventional restorations using rotary instruments
Number of subjects: 359
Study: 8757381

Group type: EXPERIMENTAL
Intervention: Ibuprofen (500 mg suppositories administered 12 and 2 hours before surgery, and every 8 hours until the third postoperative day)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Ibuprofen (500 mg suppositories)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (suppositories administered 12 and 2 hours before surgery, and every 8 hours until the third postoperative day)
Number of subjects: 22
Study: 1682907

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 microgram/kg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1.0 microgram/kg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 6
Study: 6807681

Group type: EXPERIMENTAL
Intervention: Oxprenolol (100 mg) for 24 hours
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Indomethacin (200 mg) for 24 hours
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oxprenolol + Indomethacin (100 + 200 mg) for 24 hours
Number of subjects: 8

Group type: COMPARATOR
Intervention: Low sodium diet
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normal sodium intake
Number of subjects: 8
Study: 31142454

Group type: EXPERIMENTAL
Intervention: Data from randomised clinical trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 30534562

Group type: EXPERIMENTAL
Intervention: Digital impressions
Number of subjects: 24

Group type: COMPARATOR
Intervention: Traditional impressions (Control)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups (Digital and Traditional)
Number of subjects: 24
Study: 27358067

Group type: EXPERIMENTAL
Intervention: DHA supplementation (n=29)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Placebo (n=15)
Number of subjects: 384
Study: 24698578

Group type: EXPERIMENTAL
Intervention: Modified Scapular Manipulation (MSM)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Traction-Countertraction (TCT)
Number of subjects: 97
Study: 22990854

Group type: EXPERIMENTAL
Intervention: L. reuteri NCIMB 30242 capsules
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 127
Study: 20423743

Group type: EXPERIMENTAL
Intervention: Very low-carbohydrate/high-protein (HPLC) diet
Number of subjects: 6

Group type: COMPARATOR
Intervention: Starvation
Number of subjects: 6

Group type: COMPARATOR
Intervention: Mixed-carbohydrate diet
Number of subjects: 6
Study: 17201457

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EC-mycophenolate sodium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mycophenolate therapy
Number of subjects: 0
Study: 16263350

Group type: EXPERIMENTAL
Intervention: Vascular brachytherapy (VBT) during stented angioplasty
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (stent implantation without VBT)
Number of subjects: 61
Study: 11934202

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine ophthalmic solution 0.5%
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (Lens Plus)
Number of subjects: 39
Study: 10774765

Group type: EXPERIMENTAL
Intervention: Hepatitis B surface antigen (HbsAg)
Number of subjects: 824

Group type: COMPARATOR
Intervention: No hepatitis B surface antigen (control)
Number of subjects: 824
Study: 8625175

Group type: EXPERIMENTAL
Intervention: Sho-saiko-to (TJ-9) at a daily oral dose of 7.5 g
Number of subjects: 260

Group type: COMPARATOR
Intervention: Conventional drugs (Control)
Number of subjects: 260
Study: 31241992

Group type: EXPERIMENTAL
Intervention: Spironolactone 100 mg
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Spironolactone (50 mg and 100 mg)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 29231322

Group type: EXPERIMENTAL
Intervention: Acupuncture based on nourishing spleen and kidney and dredging the governor vessel, applied for 3 sessions with 20 days at the interval, 10 times as one session, once every other day.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group received physicotherapeutics and hand function training for 3 sessions with 20 days at the interval, 20 times as one session, once a day.
Number of subjects: 120
Study: 25491792

Group type: EXPERIMENTAL
Intervention: JNJ‐39758979 100 mg
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: JNJ‐39758979 300 mg
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88

Group type: COMPARATOR
Intervention: JNJ‐39758979 and Placebo
Number of subjects: 88
Study: 23941576

Group type: EXPERIMENTAL
Intervention: Standard stroke care plus auto-BPAP initiated within 24 hours of stroke onset for a maximum of 48 hours.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard stroke care alone.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard stroke care plus auto-BPAP.
Number of subjects: 0
Study: 21480979

Group type: EXPERIMENTAL
Intervention: Melatonin (50 mg/kg BW)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Microcrystalline cellulose (Control)
Number of subjects: 50
Study: 19535182

Group type: EXPERIMENTAL
Intervention: Fast-track group (FT)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Non-fast-track group (non-FT)
Number of subjects: 105
Study: 16455421

Group type: EXPERIMENTAL
Intervention: Levosimendan (n = 26)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (n = 26)
Number of subjects: 52
Study: 14692930

Group type: EXPERIMENTAL
Intervention: Cold air analgesia
Number of subjects: 26

Group type: COMPARATOR
Intervention: Photodynamic therapy without cold air analgesia
Number of subjects: 26
Study: 11533327

Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation (HFOV)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 69
Study: 9578908

Group type: EXPERIMENTAL
Intervention: Random task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Horizontal tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vertical tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multidirectional tasks
Number of subjects: 0
Study: 7506180

Group type: EXPERIMENTAL
Intervention: Nimesulide suspension (1.5 mg/kg 3 times daily)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Paracetamol syrup (10 mg/kg 4 times daily)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Nimesulide
Number of subjects: 110

Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 110
Study: 2882288

Group type: EXPERIMENTAL
Intervention: Oral prednisolone (30 mg for children under 5, 60 mg for older children)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Oral prednisolone
Number of subjects: 140
Study: 31764165

Group type: EXPERIMENTAL
Intervention: Dismissive scenario
Number of subjects: 326

Group type: COMPARATOR
Intervention: Appropriate scenario
Number of subjects: 326
Study: 31241362

Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 1512

Group type: COMPARATOR
Intervention: iGlar
Number of subjects: 1512
Study: 28472976

Group type: EXPERIMENTAL
Intervention: DHEA supplementation (25 mg three times a day for 8 weeks)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: DHEA supplementation (in vitro)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (no DHEA supplementation)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: DHEA group (with ≥5 oocytes retrieved)
Number of subjects: 103
Study: 25595984

Group type: EXPERIMENTAL
Intervention: Real-time functional magnetic resonance imaging (rtfMRI) training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 23798587

Group type: EXPERIMENTAL
Intervention: Self-control depletion (experimental condition)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Nondepletion (control condition)
Number of subjects: 62
Study: 20228689

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 477

Group type: COMPARATOR
Intervention: No corticosteroids
Number of subjects: 477
Study: 19504088

Group type: EXPERIMENTAL
Intervention: Training of reaching using a non-robotic upper limb training device, the SMART Arm, with EMG triggered functional electrical stimulation (EMG-stim)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Training of reaching using the SMART Arm alone
Number of subjects: 42

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 42
Study: 16430794

Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg administered perioperatively
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg administered only postoperatively
Number of subjects: 540

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study: 12928319

Group type: EXPERIMENTAL
Intervention: Collaborative-group testing (group A)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Traditional individual testing (group B)
Number of subjects: 38
Study: 10638466

Group type: EXPERIMENTAL
Intervention: Total Parenteral Nutrition (TPN) for 10 days preoperatively and 9 days postoperatively
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no preoperative nutrition, 940 kcal nonprotein plus 85 g amino acids postoperatively)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 9375889

Group type: EXPERIMENTAL
Intervention: 1 mg/day of liquid folic acid
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 1608268

Group type: EXPERIMENTAL
Intervention: 5% methanolic leaf extract cream of Solanum chrysotrichum
Number of subjects: 200

Group type: COMPARATOR
Intervention: Miconazole treatment (control group)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 5% methanolic leaf extract
Number of subjects: 200
Study: 3929513

Group type: EXPERIMENTAL
Intervention: Growth hormone releasing factor (GRF) 100 micrograms
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (diluent only)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Thyrotropin-releasing hormone (TRH)
Number of subjects: 32
Study: 29451355

Group type: EXPERIMENTAL
Intervention: Hesperidin 2S
Number of subjects: 0

Group type: COMPARATOR
Intervention: In vitro model
Number of subjects: 0
Study: 28094169

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24IU twice daily)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 25763921

Group type: EXPERIMENTAL
Intervention: Balance training 3 times a week for 6 months in addition to standard pulmonary rehabilitation (PR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard pulmonary rehabilitation (PR) only
Number of subjects: 0
Study: 23736807

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard RV-PGR (comparator)
Number of subjects: 50
Study: 21493740

Group type: EXPERIMENTAL
Intervention: Icodextrin (ICO) - treated with 1.5 or 2.0 L of 7.5% icodextrin‐containing solutions
Number of subjects: 41

Group type: COMPARATOR
Intervention: Glucose (GLU) - treated with 8 L of 1.5% or 2.5% glucose
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Icodextrin (ICO)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Icodextrin (ICO) and Glucose (GLU)
Number of subjects: 41
Study: 18652267

Group type: EXPERIMENTAL
Intervention: Ceramic Primer/LinkmaxHV (CP/LMHV) with 37% phosphoric acid treatment (PA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monobond S/VariolinkIIHV (MBS/VLIIHV) with 37% phosphoric acid treatment (PA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MBS/HB/VLIIHV with various surface treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alumina blasting with each of three RBSs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All combined groups of ceramic surface treatment and resin bonding system
Number of subjects: 0
Study: 16395725

Group type: EXPERIMENTAL
Intervention: COBE Spectra version 6
Number of subjects: 60

Group type: COMPARATOR
Intervention: Haemonetics MCS(+)
Number of subjects: 60
Study: 15202989

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention
Number of subjects: 30
Study: 11564035

Group type: EXPERIMENTAL
Intervention: CAG repeats in the AR gene
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: TA repeats in the ER gene
Number of subjects: 149
Study: 10023258

Group type: EXPERIMENTAL
Intervention: Holmium:YAG laser at 0.50 W
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Holmium:YAG laser at 0.75 W
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Holmium:YAG laser at 1.00 W
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fiber sizes of 140, 245, 355, and 410 microns
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Conventional fiber after lasing
Number of subjects: 60

Group type: COMPARATOR
Intervention: All power settings
Number of subjects: 60
Study: 7817797

Group type: EXPERIMENTAL
Intervention: Idiopathic calcium stone formers (ICSF)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Healthy male controls
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Idiopathic calcium stone formers (ICSF) with low-calcium diet
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Idiopathic calcium stone formers (ICSF) with skeletal score 4
Number of subjects: 110
Study: 2648143

Group type: EXPERIMENTAL
Intervention: Standard course of methotrexate for 102 days after transplantation (Group I)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Abbreviated (11-day) course of methotrexate (Group II)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Standard course of methotrexate plus viable buffy-coat cells from marrow donors (Group III)
Number of subjects: 109
Study: 31931852

Group type: EXPERIMENTAL
Intervention: New recruitment approach with continuous information and gratification (Swiss chocolate and free soft drinks)
Number of subjects: 0
Study: 29889285

Group type: EXPERIMENTAL
Intervention: High-dose cytarabine in combination therapy (HD-ECM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard combination therapy (ECM)
Number of subjects: 0
Study: 27321554

Group type: EXPERIMENTAL
Intervention: 1% testosterone propionate (TG)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: 0.01% estradiol (EG)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo cream (CG)
Number of subjects: 69
Study: 25263372

Group type: COMPARATOR
Intervention: Phentolamine (group A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Urapidil (group B)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Urapidil combined with phentolamine (group C)
Number of subjects: 90
Study: 24045740

Group type: EXPERIMENTAL
Intervention: Chronic care management (CCM), n=282
Number of subjects: 563

Group type: COMPARATOR
Intervention: No CCM (control), n=281
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Chronic care management (CCM) for alcohol dependence
Number of subjects: 563
Study: 21358207

Group type: EXPERIMENTAL
Intervention: Weekly docetaxel (30 mg/m² on days 1, 8, and 15; q4w)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Standard docetaxel (75 mg/m² every 3 weeks; q3w)
Number of subjects: 162
Study: 19274909

Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (MBP)
Number of subjects: 99

Group type: COMPARATOR
Intervention: No mechanical bowel preparation (no MBP)
Number of subjects: 99
Study: 16616726

Group type: EXPERIMENTAL
Intervention: Amphetamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neuroendocrine hormone responses
Number of subjects: 0
Study: 12682721

Group type: EXPERIMENTAL
Intervention: Filgrastim (1 micro g.kg.24 h) for 10 days as a continuous infusion
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 27
Study: 11056751

Group type: EXPERIMENTAL
Intervention: 50%/50% heliox
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 60%/40% heliox
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 70%/30% heliox
Number of subjects: 10

Group type: COMPARATOR
Intervention: 50%/50% nitrogen/oxygen
Number of subjects: 10
Study: 8623958

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography (TEE) evaluation by three independent, blinded observers
Number of subjects: 40
Study: 1729857

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study: 6738337

Group type: EXPERIMENTAL
Intervention: 1 dose of 10 mg/kg metrifonate
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: 2 doses of 10 mg/kg metrifonate
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: 3 doses of 10 mg/kg metrifonate
Number of subjects: 286
Study: 30761523

Group type: EXPERIMENTAL
Intervention: Racecadotril (100 mg) - acute administration
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Racecadotril (100 mg; t.i.d.) - chronic administration for 14 days
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo - acute administration
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo - chronic administration for 14 days
Number of subjects: 21
Study: 30336290

Group type: EXPERIMENTAL
Intervention: Daylight photodynamic therapy (DL-PDT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional photodynamic therapy (C-PDT)
Number of subjects: 60
Study: 27115126

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS) 200 g daily during the first 3 months of ART
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Control group (ART without LNS)
Number of subjects: 282
Study: 24961851

Group type: EXPERIMENTAL
Intervention: Daily intake of DEHP estimated using the urine volume (UV) model
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Daily intake of DEHP estimated using the urine creatinine-excretion (UCE) model
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group 1 (administrators)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group 2 (laboratory technicians)
Number of subjects: 129
Study: 23264537

Group type: EXPERIMENTAL
Intervention: Polarized model (6.4 h/wk; 80% low, 0% moderate, 20% high intensity)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Threshold model (7.5 h/wk; 57% low, 43% moderate, 0% high intensity)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Polarized model
Number of subjects: 12

Group type: COMPARATOR
Intervention: Threshold model
Number of subjects: 12
Study: 20059413

Group type: EXPERIMENTAL
Intervention: Metronidazole 500 mg and Amoxicillin 375 mg, three times a day for 7 days
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Metronidazole and Amoxicillin
Number of subjects: 51
Study: 19035876

Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg daily for 4 weeks)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 76
Study: 15844840

Group type: EXPERIMENTAL
Intervention: Medicinal herb tea (MHT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-MHT taking subjects (Control)
Number of subjects: 100
Study: 14765605

Group type: EXPERIMENTAL
Intervention: Anticipation procedures involving verbal descriptions of the correct response
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Anticipation procedures requiring explicit reading of verbal descriptions
Number of subjects: 40

Group type: COMPARATOR
Intervention: Training control procedures (for 8 subjects)
Number of subjects: 40
Study: 10225812

Group type: EXPERIMENTAL
Intervention: Parenteral gold salt therapy
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Parenteral gold salt therapy (withdrawn due to side effects)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Methotrexate (withdrawn due to side effects)
Number of subjects: 128
Study: 8876346

Group type: EXPERIMENTAL
Intervention: Ginseng (GS) 8 or 16 mg/kg body weight daily for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (CN)
Number of subjects: 0
Study: 1984328

Group type: EXPERIMENTAL
Intervention: TE of 12 msec
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Fat suppression
Number of subjects: 28

Group type: COMPARATOR
Intervention: TE of 20 msec
Number of subjects: 28

Group type: COMPARATOR
Intervention: No fat suppression
Number of subjects: 28
Study: 3915287

Group type: EXPERIMENTAL
Intervention: Cefuroxime prophylaxis (1.5g every 12 h for 2 days)
Number of subjects: 512

Group type: COMPARATOR
Intervention: Ceftriaxone prophylaxis (2g i.v. plus 1g i.v. after 24 h for 2 days)
Number of subjects: 512

Group type: COMPARATOR
Intervention: Ceftriaxone prophylaxis
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Cefuroxime and Ceftriaxone prophylaxis
Number of subjects: 512
Study: 29469602

Group type: EXPERIMENTAL
Intervention: Repetitive prone press-ups
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Sustained prone press-ups
Number of subjects: 41

Group type: COMPARATOR
Intervention: Time (before vs. after press-ups)
Number of subjects: 41

Group type: COMPARATOR
Intervention: End range of motion spinal extension
Number of subjects: 41
Study: 29498469

Group type: EXPERIMENTAL
Intervention: vildagliptin (50 mg twice daily)
Number of subjects: 28

Group type: COMPARATOR
Intervention: dapagliflozin (10 mg once daily)
Number of subjects: 28
Study: 26888258

Group type: EXPERIMENTAL
Intervention: Dexamethasone (10 mg/m² per day for 3 weeks plus tapering)
Number of subjects: 3720

Group type: COMPARATOR
Intervention: Prednisone (60 mg/m² per day for 3 weeks plus tapering)
Number of subjects: 3720

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 3720

Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 3720
Study: 24020994

Group type: EXPERIMENTAL
Intervention: SumaRT/Nap (85 mg sumatriptan + 500 mg naproxen sodium)
Number of subjects: 28

Group type: COMPARATOR
Intervention: naproxen sodium (500 mg)
Number of subjects: 28
Study: 22503574

Group type: EXPERIMENTAL
Intervention: 18 mg nicotine e‐cigarette
Number of subjects: 86

Group type: COMPARATOR
Intervention: 0 mg e‐cigarette (placebo)
Number of subjects: 86

Group type: COMPARATOR
Intervention: just hold e‐cigarette
Number of subjects: 86